ACN Newswire

2024-02-28 09:00

TechInvention Lifecare announces the groundbreaking of its state-of-the-art Global Collaborative Centre for Medical Countermeasures

MUMBAI, INDIA, Feb 28, 2024 - (ACN Newswire) - In a significant stride towards enhancing global health security and pandemic preparedness, TechInvention Lifecare Pvt. Ltd. is proud to announce the ground breaking of its Global Collaborative Centre for Medical Countermeasures (GCMC) with an investment of approx. USD 15 million. The centre is strategically located close to the upcoming international airport in Navi Mumbai, India.

Prototype - Global Collaborative Centre for Medical Countermeasures (GCMC)
Prototype - Global Collaborative Centre for Medical Countermeasures (GCMC)

GCMC has been acknowledged for its global significance at the 2nd World Local Production Forum in The Hague on 6-8 November 2023, organized by the WHO. The objective of GCMC is well aligned to WHO’s call to action, CEPI’s 100 days mission, India’s National Biotechnology Development Strategy (2020-2025), and other global key initiatives.

This facility will serve the needs of both public and private organizations, such as academic institutes, start-ups, MSMEs, and R&D organizations, to provide a comprehensive ecosystem, facilitating the transition from R&D to GMP-scale production for pre-clinical/clinical batches with required regulatory approvals.

GCMC is a unique eco-friendly centre to cater to crucial medical countermeasures—the entire cycle of vaccine development, from strain to supply, biotherapeutics and diagnostics for both human and veterinary segments, while ensuring sustainable manufacturing. This initiative aligns with the One Health approach, emphasizing the interconnection between human, animal, and environmental health.

Mr. Syed S. Ahmed, Director and CEO of TechInvention, expressed, “The current challenges posed in biologics equity arise from the disparity in translational research dissemination from the centres of excellence to the regional manufacturing ‘hub and spoke’ model setups. We believe that GCMC would be the needed intervention, strengthening the hubs by providing ‘scaled-up’, regulatory-approved, cost-effective, and free of IP infringement biosolutions sourced from both indigenous research and centres of excellence worldwide”.

About TechInvention Lifecare Pvt. Ltd.: https://techinvention.biz/ 

TechInvention Lifecare Pvt. Ltd. distinguishes itself as a unique Indian biotech company, supporting the ‘One Health’ concept by integrating three pivotal interventions: diagnostics, vaccines, and biotherapeutics, catering to both human and veterinary sectors. Its innovation is dedicated to advancing global health through novel solutions. With a focus on research and development, the company is committed to addressing the health challenges that may emerge in the future.

For further details, please contact:
Mr Sarang Pathak
+91 99606 16481
sarang@techinvention.biz 



Copyright 2024 ACN Newswire. All rights reserved. www.acnnewswire.com

【慎防受騙】偽冒《經濟通》投資群組頻現,切勿誤信騙徒,如有疑問,請循官方渠道查詢► 了解詳情

人氣文章
財經新聞
評論
專題
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【嚴正聲明】《經濟通》呼籲公眾提高警覺留意偽冒《經濟通》投資群組

如何分辨問米是否真實?通靈問事用什麼工具都可以?靈靈法即場示範通靈!

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

貨幣攻略

說說心理話

Watche Trends 2024

北上食買玩

Art Month 2024

理財秘笈

夏天養生食療

消委會報告

山今養生智慧

輕鬆護老